03 October 2019
Visiongain has published a new pharma report Top 20 Advanced Wound Care Companies 2020: Smith & Nephew Plc., ConvaTec Group Plc., Coloplast A/S, 3M, B. Braun Melsungen AG and Other Companies.
Wound care is essential in improving the quality of life and overall well-being. The wound care industry is highly competitive and diverse with immense potential for growth. Drivers for growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness.
The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years.
This report profiled the selected companies: Smith & Nephew, Acelity L.P. Inc., Mölnlycke Health Care, ConvaTec Group plc, Coloplast A/S, 3M Company, B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health, Inc. and other companies.
The lead analyst commented that "Being the largest and fastest growing segment of the wound care market, the Advanced wound care market will witness healthy growth during the forecast period. Growth in this market is set to be driven by the increasing awareness of current technologies, launch of new innovative products and rapidly expanding emerging economies. During the course of the forecast period, more companies are expected to expand their operations into developing economies."
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.